Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 10:25 PM
Study NCT ID:
NCT00390858
Status:
COMPLETED
Last Update Posted:
2017-03-20
First Post:
2006-10-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2008-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-18
First Submit QC Date:
None
Study First Post Date:
2006-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-21
Results First Submit QC Date:
None
Results First Post Date:
2011-08-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-12
Last Update Post Date:
2017-03-20
Last Update Post Date Type:
ACTUAL